Background: Dysbiosis is related to changes in composition and behaviour of intestinal microbiota, which may contribute to an age-related decline in metabolic and immune system functioning (immune-senescence). Objective: The microbiota-targeted dietary and probiotic interventions have been shown to favorably affect the host health by an enhancement of antioxidant activity, improving immune homeostasis, suppression of chronic inflammation, regulation of metabolism and prevention of insulin resistance. Results: In our study, the use of specific probiotics strains improved the serum concentration of glycemic markers, thereby promoting better overall health. Conclusion: Probiotics may help correct defects in the gut microbial environment improving metabolic parameters, such as blood sugar levels, glycosylated hemoglobin and a decrease in body weight.

Evaluation of a nutraceutical product with probiotics, vitamin d, plus banaba leaf extracts (Lagerstroemia speciosa) in glycemic control

Roberto Arrigoni;
2020

Abstract

Background: Dysbiosis is related to changes in composition and behaviour of intestinal microbiota, which may contribute to an age-related decline in metabolic and immune system functioning (immune-senescence). Objective: The microbiota-targeted dietary and probiotic interventions have been shown to favorably affect the host health by an enhancement of antioxidant activity, improving immune homeostasis, suppression of chronic inflammation, regulation of metabolism and prevention of insulin resistance. Results: In our study, the use of specific probiotics strains improved the serum concentration of glycemic markers, thereby promoting better overall health. Conclusion: Probiotics may help correct defects in the gut microbial environment improving metabolic parameters, such as blood sugar levels, glycosylated hemoglobin and a decrease in body weight.
2020
Istituto di Biomembrane, Bioenergetica e Biotecnologie Molecolari (IBIOM)
Banaba leaf extracts;
Lagerstroemia speciosa.;
Probiotics;
Vitamin D;
cholecalciferol;
translational medicine.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/425011
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact